Creation of a defined and stable Fontan fenestration with the new Occlutech Atrial Flow Regulator (AFR®)
Authors:
- 4 July 2018
- journal article
- research article
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 28 (8) , 1062-1066
Abstract
This report describes the first clinical experience with the new Occlutech Atrial Flow Regulator (AFR®) device for implementation of a late Fontan fenestration. The AFR® device secured a defined diameter of the fenestration without spontaneous re-occlusion of this extra-anatomic perforation. This ensured a permanent clinical improvement of our failing Fontan patient.Keywords
This publication has 14 references indexed in Scilit:
- Catheter interventions in the staged management of hypoplastic left heart syndromeCardiology in the Young, 2013
- Transhepatic Approach for Extracardiac Inferior Cavopulmonary Connection Stent FenestrationCongenital Heart Disease, 2011
- Shunt reduction with a fenestrated Amplatzer deviceCatheterization and Cardiovascular Interventions, 2010
- Percutaneous transcatheter communication between the pulmonary artery and atrium following an extra‐cardiac FontanCatheterization and Cardiovascular Interventions, 2008
- Efficacy and long‐term patency of fenestrated amplatzer devices in childrenCatheterization and Cardiovascular Interventions, 2007
- Results of transcatheter Fontan fenestration to treat protein losing enteropathyCatheterization and Cardiovascular Interventions, 2007
- Clinical outcome of patients 20 years after Fontan operation — effect of fenestration on late morbidityEuropean Journal of Cardio-Thoracic Surgery, 2006
- Use of Stents to Maintain Atrial Defects and Fontan Fenestrations in Congenital Heart DiseaseJournal of Interventional Cardiology, 2005
- Fenestration Improves Clinical Outcome of the Fontan ProcedureCirculation, 2002
- Transcatheter Fenestration Dilation and/or Creation in Postoperative Fontan PatientsThe American Journal of Cardiology, 1997